SlideShare a Scribd company logo
© PBL Solutions Ltd
PBL Solutions Ltd
Pharma, Biotech & Big Data
Guiding Market Entry into Complex and
Diverse Regulatory Environments
PBL Solutions Ltd Capabilities
© PBL Solutions Ltd
PBL Solutions Ltd
Expert in:
Negotiating Business Development Agreements
Assessing opportunity and market access barriers
Identifying key stake holders and how best to influence them
Hands-on negotiation (Regulators, MOH, Procurement groups)
Execution within complex and dynamic markets
© PBL Solutions Ltd
PBL Solutions Ltd
Specific Recent Engagements
• Highly successful business development track record leading to in-licensing
of more than 18 products in 2014/15, across multiple territories in ASEAN
and ANZ
• Established numerous key opinion leader networks across the region in
different therapeutic areas
• Completed an Entry Point Project (EPP) with the Malaysian government
• Negotiation with regulatory agencies, Ministry of Health, and other
Government agencies concerning multiple filings
3
© PBL Solutions Ltd
PBL Solutions Ltd
The Value PBL can Offer
• A senior level consultancy to cover multiple territories
• An analytical approach to business leveraging big pharma and biotech
experience at Vice President level
• Demonstrable Marketing and Branding thought leadership
• Identifying the right partners
• Government or semi-government organizations
• Companies operating in multiple territories
• Specialist local companies market-by-market
• Ability to leverage strategic knowledge of highly specialised areas
• Branded generic strategies
• Specialist Rx product entry
• Real World Data (Pharma Big Data)
• Cell Therapies
4
© PBL Solutions Ltd
PBL Solutions Ltd
Specific skill sets
• Local market knowledge with hands-on negotiation experience
• The ability to use P&L data
• Identifying executable actions
• Backed up by insightful Board level communication (presentation and reports)
• Skilled negotiation of contracts and agreements to deliver high performance
• Regulatory
• Distribution
• Promotional
• Manufacturing
• Significant experience in settling legal entity and manufacturing issues
5
© PBL Solutions Ltd
PBL Solutions Ltd
Principle Consultant: Giles D. Moss
• First Career Key Achievements
• Rose through the ranks at BMS, Sandoz and SmithKline Beecham to become
VP Operations Europe (Region 1) at UCB Pharma.
• Consistently delivering above budget EBIT in two regional roles covering 17
markets in Asia Pacific and Europe.
• Signed successful BD deals in Indonesia, Australia, and the Philippines.
• Second Career Key Achievements
• Identifying AP regulatory and commercial partners for a biosimilar and a
specialist Rx company.
• Evaluation of business models for Asia Pacific.
• Negotiation of distribution and promotional agreements in Australia, Sri
Lanka, Indonesia and the Philippines for a UK branded company
• Resolution of complex legal entity, manufacturing and promotional issues
for a newly acquired Rx business in Indonesia.
• Key player in an unsuccessful MBO funded by a Middle East Sovereign
Wealth Fund.
• Author of the book “Pharmaceuticals – Where’s the Brand
Logic” Published in America.
• http://www.amazon.com/Pharmaceuticals-wheres-Brand-Logic-Branding-Strategy/dp/0789032589/ref=sr_1_1?ie=UTF8&s=books&qid=1302149846&sr=8-
6
© PBL Solutions Ltd
PBL Solutions Ltd
Further Project Information
July 2, 2016 7
© PBL Solutions Ltd
PBL Solutions Ltd
Examples of Recent or On-going Projects
• Engagements examples:
• Evaluation of business models for regional entry
• Biosimilar partnering assessment
• Partner identification (regulatory and commercial) for a specialist Rx company
• Negotiation of distribution and promotional agreements in Australia, Sri Lanka,
Indonesia and the Philippines for a branded Rx company
• Resolution of complex legal entity, manufacturing and promotional issues for
an acquired business in Indonesia
• Assessment of data technology advances in Europe and future application
• Delivery of branded generic launch plans for three markets (Thailand, Malaysia
and Hong Kong)
8
© PBL Solutions Ltd
PBL Solutions Ltd
Service Example
9
• Finding ideal partners:
• Preparation of confidential data package to start negotiations
• Partner search & initial contacts/visits
• Establishing each potential partners pro’s and con’s
• Preparation and attendance at client meeting with potential partners
• Upon request
• Set-up potential deal structure
• Lead negotiation process
• Complete term sheet
• Follow through to executed legal agreement
• PBL services are available as a complete package or can be individually selected depending on specific needs
© PBL Solutions Ltd
PBL Solutions Ltd
Service Example
• Strategic market entry strategy
• Matching a client portfolio to market opportunity
• Molecule and presentation review
• Market potential estimation
• Segmentation by customer grouping
• Initial field interviews to check customer reaction to proposed portfolio
• Regulatory assessment and planning
• Setting the level of ambition and final country selection
• Portfolio sales forecasts and creation of P&Ls
• Agreement of investment levels and timelines
• Creation of launch plans
• Identifying executable actions
• Guiding implementation where appropriate
• PBL services are available as a complete package or can be individually selected depending on specific needs
10
© PBL Solutions Ltd
PBL Solutions Ltd
Contact details
• General Enquiries
• Giles D. Moss
• giles.moss@pharmabrandlogic.com
• Telephone +60193725670
• Skype: giles.moss1
11

More Related Content

Viewers also liked

How to avoid Random Association Syndrome: Getting value from Big Health Data.
How to avoid Random Association Syndrome: Getting value from Big Health Data.How to avoid Random Association Syndrome: Getting value from Big Health Data.
How to avoid Random Association Syndrome: Getting value from Big Health Data.
Tracy Allison Altman
 
Delivering Real-Time Business Value for Healthcare
Delivering Real-Time Business Value for HealthcareDelivering Real-Time Business Value for Healthcare
Delivering Real-Time Business Value for Healthcare
SAP Technology
 
Delivering Real-Time Business Value for Life Sciences
Delivering Real-Time Business Value for Life SciencesDelivering Real-Time Business Value for Life Sciences
Delivering Real-Time Business Value for Life Sciences
SAP Technology
 
Integrity Auditing Of Dynamic Cloud Data With Group User Revocation
Integrity Auditing Of Dynamic Cloud Data With Group User RevocationIntegrity Auditing Of Dynamic Cloud Data With Group User Revocation
Integrity Auditing Of Dynamic Cloud Data With Group User Revocation
JSPM's JSCOE , Pune Maharashtra.
 
Nova Discovery - Advancing 4P medicine with the EISBM
Nova Discovery - Advancing 4P medicine with the EISBMNova Discovery - Advancing 4P medicine with the EISBM
Nova Discovery - Advancing 4P medicine with the EISBM
European Institute for Systems Biology & Medicine.
 
Pharma new bus model St Petersburg Russia
Pharma new bus model St Petersburg RussiaPharma new bus model St Petersburg Russia
Pharma new bus model St Petersburg Russia
A.R.J. (Rob) Halkes
 
HEALTH CARE & PHARMACEUTICAL BUSINESS: KEY CHALLENGES & IT VALUE
HEALTH CARE & PHARMACEUTICAL BUSINESS: KEY CHALLENGES & IT VALUEHEALTH CARE & PHARMACEUTICAL BUSINESS: KEY CHALLENGES & IT VALUE
HEALTH CARE & PHARMACEUTICAL BUSINESS: KEY CHALLENGES & IT VALUE
Mauricio Campos Suarez
 
Healthcare business intelligence
Healthcare business intelligenceHealthcare business intelligence
Healthcare business intelligence
Carolina Health Informatics Program @ UNC
 
Fight cancer with personalized medicine
Fight cancer with personalized medicineFight cancer with personalized medicine
Fight cancer with personalized medicine
Avi Dey
 
Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectivePM Society
 
Forum on Personalized Medicine: Challenges for the next decade
Forum on Personalized Medicine: Challenges for the next decadeForum on Personalized Medicine: Challenges for the next decade
Forum on Personalized Medicine: Challenges for the next decade
Joaquin Dopazo
 
Genomic Medicine: Personalized Care for Just Pennies
Genomic Medicine: Personalized Care for Just PenniesGenomic Medicine: Personalized Care for Just Pennies
Genomic Medicine: Personalized Care for Just Pennies
Health Catalyst
 
Personalized Medicine: Current and Future Perspectives Personalized Medicin...
Personalized Medicine: Current and Future Perspectives 	 Personalized Medicin...Personalized Medicine: Current and Future Perspectives 	 Personalized Medicin...
Personalized Medicine: Current and Future Perspectives Personalized Medicin...MedicineAndHealth
 
Oscar health insurance
Oscar health insuranceOscar health insurance
Oscar health insurance
Jeffrey Funk Business Models
 
Controversies in patents
Controversies in patentsControversies in patents
Controversies in patentsedsiew
 
La santé numérique, la médecine 4P et les assurances
La santé numérique,  la médecine 4P  et les assurancesLa santé numérique,  la médecine 4P  et les assurances
La santé numérique, la médecine 4P et les assurances
Alain Tassy
 
Towards Personalized Medicine
Towards Personalized MedicineTowards Personalized Medicine
Towards Personalized Medicine
Michel Dumontier
 
Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animalsdamarisb
 
Developing Metrics and KPI (Key Performance Indicators
Developing Metrics and KPI (Key Performance IndicatorsDeveloping Metrics and KPI (Key Performance Indicators
Developing Metrics and KPI (Key Performance Indicators
Victor Holman
 
Big Data Solutions for Healthcare
Big Data Solutions for HealthcareBig Data Solutions for Healthcare
Big Data Solutions for HealthcareOdinot Stanislas
 

Viewers also liked (20)

How to avoid Random Association Syndrome: Getting value from Big Health Data.
How to avoid Random Association Syndrome: Getting value from Big Health Data.How to avoid Random Association Syndrome: Getting value from Big Health Data.
How to avoid Random Association Syndrome: Getting value from Big Health Data.
 
Delivering Real-Time Business Value for Healthcare
Delivering Real-Time Business Value for HealthcareDelivering Real-Time Business Value for Healthcare
Delivering Real-Time Business Value for Healthcare
 
Delivering Real-Time Business Value for Life Sciences
Delivering Real-Time Business Value for Life SciencesDelivering Real-Time Business Value for Life Sciences
Delivering Real-Time Business Value for Life Sciences
 
Integrity Auditing Of Dynamic Cloud Data With Group User Revocation
Integrity Auditing Of Dynamic Cloud Data With Group User RevocationIntegrity Auditing Of Dynamic Cloud Data With Group User Revocation
Integrity Auditing Of Dynamic Cloud Data With Group User Revocation
 
Nova Discovery - Advancing 4P medicine with the EISBM
Nova Discovery - Advancing 4P medicine with the EISBMNova Discovery - Advancing 4P medicine with the EISBM
Nova Discovery - Advancing 4P medicine with the EISBM
 
Pharma new bus model St Petersburg Russia
Pharma new bus model St Petersburg RussiaPharma new bus model St Petersburg Russia
Pharma new bus model St Petersburg Russia
 
HEALTH CARE & PHARMACEUTICAL BUSINESS: KEY CHALLENGES & IT VALUE
HEALTH CARE & PHARMACEUTICAL BUSINESS: KEY CHALLENGES & IT VALUEHEALTH CARE & PHARMACEUTICAL BUSINESS: KEY CHALLENGES & IT VALUE
HEALTH CARE & PHARMACEUTICAL BUSINESS: KEY CHALLENGES & IT VALUE
 
Healthcare business intelligence
Healthcare business intelligenceHealthcare business intelligence
Healthcare business intelligence
 
Fight cancer with personalized medicine
Fight cancer with personalized medicineFight cancer with personalized medicine
Fight cancer with personalized medicine
 
Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma Perspective
 
Forum on Personalized Medicine: Challenges for the next decade
Forum on Personalized Medicine: Challenges for the next decadeForum on Personalized Medicine: Challenges for the next decade
Forum on Personalized Medicine: Challenges for the next decade
 
Genomic Medicine: Personalized Care for Just Pennies
Genomic Medicine: Personalized Care for Just PenniesGenomic Medicine: Personalized Care for Just Pennies
Genomic Medicine: Personalized Care for Just Pennies
 
Personalized Medicine: Current and Future Perspectives Personalized Medicin...
Personalized Medicine: Current and Future Perspectives 	 Personalized Medicin...Personalized Medicine: Current and Future Perspectives 	 Personalized Medicin...
Personalized Medicine: Current and Future Perspectives Personalized Medicin...
 
Oscar health insurance
Oscar health insuranceOscar health insurance
Oscar health insurance
 
Controversies in patents
Controversies in patentsControversies in patents
Controversies in patents
 
La santé numérique, la médecine 4P et les assurances
La santé numérique,  la médecine 4P  et les assurancesLa santé numérique,  la médecine 4P  et les assurances
La santé numérique, la médecine 4P et les assurances
 
Towards Personalized Medicine
Towards Personalized MedicineTowards Personalized Medicine
Towards Personalized Medicine
 
Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animals
 
Developing Metrics and KPI (Key Performance Indicators
Developing Metrics and KPI (Key Performance IndicatorsDeveloping Metrics and KPI (Key Performance Indicators
Developing Metrics and KPI (Key Performance Indicators
 
Big Data Solutions for Healthcare
Big Data Solutions for HealthcareBig Data Solutions for Healthcare
Big Data Solutions for Healthcare
 

Similar to PBL Solutions Capabilities - June 2016 - small file size

CV_MarkMcEwen v8
CV_MarkMcEwen v8CV_MarkMcEwen v8
CV_MarkMcEwen v8Mark McEwen
 
The ROI of a TrinityP3 managed agency pitch
The ROI of a TrinityP3 managed agency pitchThe ROI of a TrinityP3 managed agency pitch
The ROI of a TrinityP3 managed agency pitch
TrinityP3 Marketing Management Consultants
 
BIO 2014 Business Dev Fundamentals Course_Strategic Alliances_MWYoung 140620
BIO 2014 Business Dev Fundamentals Course_Strategic Alliances_MWYoung 140620 BIO 2014 Business Dev Fundamentals Course_Strategic Alliances_MWYoung 140620
BIO 2014 Business Dev Fundamentals Course_Strategic Alliances_MWYoung 140620
Michael W. Young
 
BFS Capability & Services Version AUG 2016
BFS Capability & Services Version AUG 2016BFS Capability & Services Version AUG 2016
BFS Capability & Services Version AUG 2016Nikhil Shah
 
Resume Kathy Hart 2016 General
Resume Kathy Hart 2016 GeneralResume Kathy Hart 2016 General
Resume Kathy Hart 2016 GeneralKathy Hart
 
PPT presentation of Marketing Professional Services In Asia Seminar at Cim HK...
PPT presentation of Marketing Professional Services In Asia Seminar at Cim HK...PPT presentation of Marketing Professional Services In Asia Seminar at Cim HK...
PPT presentation of Marketing Professional Services In Asia Seminar at Cim HK...
Robert_Sawhney
 
Aagami Technology Licensing Presentation
Aagami Technology Licensing PresentationAagami Technology Licensing Presentation
Aagami Technology Licensing Presentation
Aagami, Inc.
 
Target Account Planning session
Target Account Planning sessionTarget Account Planning session
Target Account Planning sessionTony Shepherd
 
Re con capabilities2013forlinkedin
Re con capabilities2013forlinkedinRe con capabilities2013forlinkedin
Re con capabilities2013forlinkedinSal Cofoni
 
Re con capabilities2013forlinkedin
Re con capabilities2013forlinkedinRe con capabilities2013forlinkedin
Re con capabilities2013forlinkedinDean1775
 
SLA Negotiation
SLA NegotiationSLA Negotiation
SLA Negotiation
Sophia Guevara
 
Vivaan company profile
Vivaan company profileVivaan company profile
Vivaan company profileSameer Kachole
 
Job discription vishu__26-9-2016
Job discription vishu__26-9-2016Job discription vishu__26-9-2016
Job discription vishu__26-9-2016
Siddharth Sundriyal
 
Art of the deal 101: Notes from the Trenches - Entrepreneurship 101
Art of the deal 101: Notes from the Trenches - Entrepreneurship 101Art of the deal 101: Notes from the Trenches - Entrepreneurship 101
Art of the deal 101: Notes from the Trenches - Entrepreneurship 101
MaRS Discovery District
 
Abhay Kumar CV FINAL 2015 CEO
Abhay Kumar CV FINAL 2015 CEOAbhay Kumar CV FINAL 2015 CEO
Abhay Kumar CV FINAL 2015 CEOAbhay Kumar
 
WMS Consulting English version 3003
WMS Consulting English version 3003WMS Consulting English version 3003
WMS Consulting English version 3003Waldemar Marchetti
 

Similar to PBL Solutions Capabilities - June 2016 - small file size (20)

Shyam Sundar profile
Shyam Sundar profileShyam Sundar profile
Shyam Sundar profile
 
CV_MarkMcEwen v8
CV_MarkMcEwen v8CV_MarkMcEwen v8
CV_MarkMcEwen v8
 
The ROI of a TrinityP3 managed agency pitch
The ROI of a TrinityP3 managed agency pitchThe ROI of a TrinityP3 managed agency pitch
The ROI of a TrinityP3 managed agency pitch
 
NC CV 106
NC CV 106NC CV 106
NC CV 106
 
BIO 2014 Business Dev Fundamentals Course_Strategic Alliances_MWYoung 140620
BIO 2014 Business Dev Fundamentals Course_Strategic Alliances_MWYoung 140620 BIO 2014 Business Dev Fundamentals Course_Strategic Alliances_MWYoung 140620
BIO 2014 Business Dev Fundamentals Course_Strategic Alliances_MWYoung 140620
 
BFS Capability & Services Version AUG 2016
BFS Capability & Services Version AUG 2016BFS Capability & Services Version AUG 2016
BFS Capability & Services Version AUG 2016
 
Resume Kathy Hart 2016 General
Resume Kathy Hart 2016 GeneralResume Kathy Hart 2016 General
Resume Kathy Hart 2016 General
 
PPT presentation of Marketing Professional Services In Asia Seminar at Cim HK...
PPT presentation of Marketing Professional Services In Asia Seminar at Cim HK...PPT presentation of Marketing Professional Services In Asia Seminar at Cim HK...
PPT presentation of Marketing Professional Services In Asia Seminar at Cim HK...
 
Aagami Technology Licensing Presentation
Aagami Technology Licensing PresentationAagami Technology Licensing Presentation
Aagami Technology Licensing Presentation
 
Target Account Planning session
Target Account Planning sessionTarget Account Planning session
Target Account Planning session
 
Re con capabilities2013forlinkedin
Re con capabilities2013forlinkedinRe con capabilities2013forlinkedin
Re con capabilities2013forlinkedin
 
Re con capabilities2013forlinkedin
Re con capabilities2013forlinkedinRe con capabilities2013forlinkedin
Re con capabilities2013forlinkedin
 
SLA Negotiation
SLA NegotiationSLA Negotiation
SLA Negotiation
 
Vivaan company profile
Vivaan company profileVivaan company profile
Vivaan company profile
 
Job discription vishu__26-9-2016
Job discription vishu__26-9-2016Job discription vishu__26-9-2016
Job discription vishu__26-9-2016
 
Art of the deal 101: Notes from the Trenches - Entrepreneurship 101
Art of the deal 101: Notes from the Trenches - Entrepreneurship 101Art of the deal 101: Notes from the Trenches - Entrepreneurship 101
Art of the deal 101: Notes from the Trenches - Entrepreneurship 101
 
CEB Buyer profiles
CEB Buyer profilesCEB Buyer profiles
CEB Buyer profiles
 
Abhay Kumar CV FINAL 2015 CEO
Abhay Kumar CV FINAL 2015 CEOAbhay Kumar CV FINAL 2015 CEO
Abhay Kumar CV FINAL 2015 CEO
 
Manohar Prabhu
Manohar PrabhuManohar Prabhu
Manohar Prabhu
 
WMS Consulting English version 3003
WMS Consulting English version 3003WMS Consulting English version 3003
WMS Consulting English version 3003
 

PBL Solutions Capabilities - June 2016 - small file size

  • 1. © PBL Solutions Ltd PBL Solutions Ltd Pharma, Biotech & Big Data Guiding Market Entry into Complex and Diverse Regulatory Environments PBL Solutions Ltd Capabilities
  • 2. © PBL Solutions Ltd PBL Solutions Ltd Expert in: Negotiating Business Development Agreements Assessing opportunity and market access barriers Identifying key stake holders and how best to influence them Hands-on negotiation (Regulators, MOH, Procurement groups) Execution within complex and dynamic markets
  • 3. © PBL Solutions Ltd PBL Solutions Ltd Specific Recent Engagements • Highly successful business development track record leading to in-licensing of more than 18 products in 2014/15, across multiple territories in ASEAN and ANZ • Established numerous key opinion leader networks across the region in different therapeutic areas • Completed an Entry Point Project (EPP) with the Malaysian government • Negotiation with regulatory agencies, Ministry of Health, and other Government agencies concerning multiple filings 3
  • 4. © PBL Solutions Ltd PBL Solutions Ltd The Value PBL can Offer • A senior level consultancy to cover multiple territories • An analytical approach to business leveraging big pharma and biotech experience at Vice President level • Demonstrable Marketing and Branding thought leadership • Identifying the right partners • Government or semi-government organizations • Companies operating in multiple territories • Specialist local companies market-by-market • Ability to leverage strategic knowledge of highly specialised areas • Branded generic strategies • Specialist Rx product entry • Real World Data (Pharma Big Data) • Cell Therapies 4
  • 5. © PBL Solutions Ltd PBL Solutions Ltd Specific skill sets • Local market knowledge with hands-on negotiation experience • The ability to use P&L data • Identifying executable actions • Backed up by insightful Board level communication (presentation and reports) • Skilled negotiation of contracts and agreements to deliver high performance • Regulatory • Distribution • Promotional • Manufacturing • Significant experience in settling legal entity and manufacturing issues 5
  • 6. © PBL Solutions Ltd PBL Solutions Ltd Principle Consultant: Giles D. Moss • First Career Key Achievements • Rose through the ranks at BMS, Sandoz and SmithKline Beecham to become VP Operations Europe (Region 1) at UCB Pharma. • Consistently delivering above budget EBIT in two regional roles covering 17 markets in Asia Pacific and Europe. • Signed successful BD deals in Indonesia, Australia, and the Philippines. • Second Career Key Achievements • Identifying AP regulatory and commercial partners for a biosimilar and a specialist Rx company. • Evaluation of business models for Asia Pacific. • Negotiation of distribution and promotional agreements in Australia, Sri Lanka, Indonesia and the Philippines for a UK branded company • Resolution of complex legal entity, manufacturing and promotional issues for a newly acquired Rx business in Indonesia. • Key player in an unsuccessful MBO funded by a Middle East Sovereign Wealth Fund. • Author of the book “Pharmaceuticals – Where’s the Brand Logic” Published in America. • http://www.amazon.com/Pharmaceuticals-wheres-Brand-Logic-Branding-Strategy/dp/0789032589/ref=sr_1_1?ie=UTF8&s=books&qid=1302149846&sr=8- 6
  • 7. © PBL Solutions Ltd PBL Solutions Ltd Further Project Information July 2, 2016 7
  • 8. © PBL Solutions Ltd PBL Solutions Ltd Examples of Recent or On-going Projects • Engagements examples: • Evaluation of business models for regional entry • Biosimilar partnering assessment • Partner identification (regulatory and commercial) for a specialist Rx company • Negotiation of distribution and promotional agreements in Australia, Sri Lanka, Indonesia and the Philippines for a branded Rx company • Resolution of complex legal entity, manufacturing and promotional issues for an acquired business in Indonesia • Assessment of data technology advances in Europe and future application • Delivery of branded generic launch plans for three markets (Thailand, Malaysia and Hong Kong) 8
  • 9. © PBL Solutions Ltd PBL Solutions Ltd Service Example 9 • Finding ideal partners: • Preparation of confidential data package to start negotiations • Partner search & initial contacts/visits • Establishing each potential partners pro’s and con’s • Preparation and attendance at client meeting with potential partners • Upon request • Set-up potential deal structure • Lead negotiation process • Complete term sheet • Follow through to executed legal agreement • PBL services are available as a complete package or can be individually selected depending on specific needs
  • 10. © PBL Solutions Ltd PBL Solutions Ltd Service Example • Strategic market entry strategy • Matching a client portfolio to market opportunity • Molecule and presentation review • Market potential estimation • Segmentation by customer grouping • Initial field interviews to check customer reaction to proposed portfolio • Regulatory assessment and planning • Setting the level of ambition and final country selection • Portfolio sales forecasts and creation of P&Ls • Agreement of investment levels and timelines • Creation of launch plans • Identifying executable actions • Guiding implementation where appropriate • PBL services are available as a complete package or can be individually selected depending on specific needs 10
  • 11. © PBL Solutions Ltd PBL Solutions Ltd Contact details • General Enquiries • Giles D. Moss • giles.moss@pharmabrandlogic.com • Telephone +60193725670 • Skype: giles.moss1 11